The largest cotton seed company in the world is Bayer.

The second largest? A seemingly tiny Hyderabad-based agri-biotech company that recently bought the Indian cotton businesses of two agricultural giants — Monsanto and DuPont Pioneer.

Today, Tierra Agrotech Private Limited owns Asia’s largest collection of cotton germplasm.

That’s decades of research. Hundreds of crores of investment. Seven truckloads of seed that arrived in air-conditioned tractor trailers at Tierra’s headquarters in the village of Dabilpur, on the outskirts of Hyderabad, earlier this year. This instantly vaulted the company into India’s top 10 list. Thanks to its seed wealth, six-year-old Tierra now has the power to shape Indian agriculture.

In Tierra’s modest Hyderabad headquarters, an assistant brings hot water in a pint glass to Suresh Atluri, CEO and co-founder. He’s wearing dad jeans, a white shirt, self-tinting glasses and a grin. “It’s not Budweiser beer,” he kids.

“Beer cannot be clear,” says Parthasarathi Bhattacharya, research director and co-founder, quite seriously.

“We don’t know, somebody will manufacture white beer, like white wine.” Atluri cracks up.

These are heady times. The company is on track this year to earn Rs 111 crore ($15.5 million) in revenue, primarily from selling Monsanto’s cotton seed inventory, according to Atluri. If true, that’d be 10x Tierra’s Rs 11 crore ($1.5 million) revenue last year. Plus, it had Rs 3 crore ($417,630) in losses, according to financial statements. Then, in August 2017, it was acquired by Grandeur Products Ltd., a Hyderabad-based listed company that pivoted suddenly from selling coffee products to selling seeds. Grandeur paid an unspecified sum for Monsanto’s cotton business and $1.84 million (Rs 13 crore) for DuPont’s, according to stock exchange filings. (The promoters of Grandeur are affiliated with CCL Products (India) Pvt. Ltd.—one of the world’s largest instant coffee manufacturers, which made a Rs 168 crore profit in 2017).

"The MNCs were doing research but they had a disconnect between research and marketing. They have so many products in the pipeline, but they are not in the market."

Parthasarathi Bhattacharya, research director, Tierra (left; Suresh Atluri is on the right)

The Monsanto purchase made Tierra the target of anti-GMO activists, who believe that genetically altered crops can have disastrous health and ecological effects. Vandana Shiva, an environmental activist, wrote to Indian regulators this year, “Monsanto is pretending to have ‘sold’ business to a four-year-old company Tierra Agrotech… This asset sale needs urgent investigation.”

The acquisitions are fallout from global dealmaking (read our previous story here). Since 2016, six global agricultural giants have merged into three: Bayer-Monsanto, DowDuPont (its agriculture division is now called Corteva Agriscience) and ChemChina-Syngenta. They own 61% of the global seed and pesticide market.

AUTHOR

Gayathri Vaidyanathan

Gayathri writes on health, environment and science. She has reported and produced stories for the Washington Post, Discover, Nature, and the New York Times, amongst other publications. In her last assignment, she was the lead science writer for E&E News in Washington, D.C. E&E News is a news organisation focused on energy and the environment. Over the past decade, Gayathri has travelled across North America, Africa and Asia on long-form reporting projects. She has a master’s in journalism from Columbia University and a bachelor's in biochemistry from McMaster University in Ontario. At The Ken, Gayathri will write on healthcare, the pharmaceutical business and the environment. Based in Bengaluru, you can reach her at gayathri at the rate the-ken.com

View Full Profile

Available exclusively to subscribers of The Ken India

This story is a part of The Ken India edition. Subscribe. Questions?

MOST POPULAR

Annual Subscription

12-month access to 200+ stories, archive of 800+ stories from our India edition. Plus our premium newsletters, Beyond The First Order and The Nutgraf worth Rs. 99/month or $2/month each for free.

Rs. 2,750

Subscribe
 

Quarterly Subscription

3-month access to 60+ new stories with 3-months worth of archives from our India edition. Plus our premium newsletters, Beyond The First Order and The Nutgraf worth Rs. 99/month or $2/month each for free.

Rs. 1,750

Subscribe
 

Single Story

Instant access to this story for a year along with comment privileges.

Rs. 500

Subscribe
MOST POPULAR

Annual Subscription

12-month access to 150+ stories from Southeast Asia.

$ 120

Subscribe
 

Quarterly Subscription

3-month access to 35+ stories from Southeast Asia.

$ 50

Subscribe
 

Single Story

Instant access to this story for a year along with comment privileges.

$ 20

Subscribe

Questions?

What is The Ken?

The Ken is a subscription-only business journalism website and app that provides coverage across two editions - India and Southeast Asia.

What kind of stories do you write?

We publish sharp, original and reported stories on technology, business and healthcare. Our stories are forward-looking, analytical and directional — supported by data, visualisations and infographics.

We use language and narrative that is accessible to even lay readers. And we optimise for quality over quantity, every single time.

What do I get if I subscribe?

For subscribers of the India edition, we publish a new story every weekday, a premium daily newsletter, Beyond The First Order and a weekly newsletter - The Nutgraf.

For subscribers of the Southeast Asia edition, we publish a new story three days a week and a weekly newsletter, Strait Up.

The annual subscription will get you complete, exclusive access to our archive of previously published stories for your edition, along with access to our subscriber-only mobile apps, our premium comment sections, our newsletter archives and several other gifts and benefits.

Do I need to pay separately for your premium newsletters?

Nope. Paid, premium subscribers of The Ken get our newsletters delivered for free.

Does a subscription to the India edition grant me access to Southeast Asia stories? Or vice-versa?

Afraid not. Each edition is separate with its own subscription plan. The India edition publishes stories focused on India. The Southeast Asia edition is focused on Southeast Asia. We may occasionally cross-publish stories from one edition to the other.

Do you offer an all-access joint subscription for both editions?

Not yet. If you’d like to access both editions, you’ll have to purchase two subscriptions separately - one for India and the other for Southeast Asia.

Do you offer any discounts?

No. We have a zero discounts policy.

Is there a free trial I can opt for?

We don’t offer any trials, but you can sign up for a free account which will give you access to the weekly free story, our archive of free stories and summaries of the paid stories. You can stay on the free account as long as you’d like.

Do you offer refunds?

We allow you to sample our journalism for free before signing up, and after you do, we stand by its quality. But we do not offer refunds.

I am facing some trouble purchasing a subscription. What can I do?

Please write to us at [email protected] detailing the error or queries.